Desonide

Product manufactured by Cintex Services, Llc

Application Nr Approved Date Route Status External Links
ANDA202470 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Desonide Gel, 0.05% Is Indicated For The Treatment Of Mild To Moderate Atopic Dermatitis In Patients 3 Months Of Age And Older. Patients Should Be Instructed To Use Desonide Gel, 0.05% For The Minimum Amount Of Time As Necessary To Achieve The Desired Results Because Of The Potential For Desonide Gel, 0.05% To Suppress The Hypothalamicpituitary-Adrenal (Hpa) Axis [See Warnings And Precautions ( 5.1 )]. Treatment Should Not Exceed 4 Consecutive Weeks [See Dosage And Administration ( 2 )]. Desonide Gel, 0.05% Is A Corticosteroid Indicated For The Topical Treatment Of Mild To Moderate Atopic Dermatitis In Patients 3 Months Of Age And Older. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Desonide DESONIDE ZINC4212851

Comments